Cell therapy · developed by Vericel
Cultured Bone Marrow Tissue is a cell-based preparation of bone marrow tissue grown in culture. It is studied in patients with ununited fractures and pseudarthrosis, conditions in which a broken bone fails to heal.
Summary written with AI from the sources listed at the end of this page.
| Trial | Phase | Condition | Status | Sponsor |
|---|---|---|---|---|
| NCT00424567 | Phase 1/2 | Fracture, Ununited | Terminated | VCEL |
Trials of the companies BioRadar tracks, from ClinicalTrials.gov, most advanced phase first.
Fracture, UnunitedPseudarthrosis
See VCEL's upcoming FDA decisions, trial readouts, cash runway and dilution risk, updated every day from SEC, FDA and ClinicalTrials.gov filings.
VCEL catalysts and pipeline →